217 related articles for article (PubMed ID: 34818414)
21. Sensitivity of adult T-cell leukaemia lymphoma cells to tumour necrosis factor-related apoptosis-inducing ligand.
Hasegawa H; Yamada Y; Harasawa H; Tsuji T; Murata K; Sugahara K; Tsuruda K; Ikeda S; Imaizumi Y; Tomonaga M; Masuda M; Takasu N; Kamihira S
Br J Haematol; 2005 Jan; 128(2):253-65. PubMed ID: 15638862
[TBL] [Abstract][Full Text] [Related]
22. ETS1 is a novel transcriptional regulator of adult T-cell leukemia/lymphoma of North American descent.
Luchtel RA; Zhao Y; Aggarwal RK; Pradhan K; Maqbool SB
Blood Adv; 2022 Oct; 6(20):5613-5624. PubMed ID: 35675522
[TBL] [Abstract][Full Text] [Related]
23. Treatment of adult T-cell leukemia/lymphoma: past, present, and future.
Ishitsuka K; Tamura K
Eur J Haematol; 2008 Mar; 80(3):185-96. PubMed ID: 18081707
[TBL] [Abstract][Full Text] [Related]
24. Downregulation of CDKN1A in adult T-cell leukemia/lymphoma despite overexpression of CDKN1A in human T-lymphotropic virus 1-infected cell lines.
Watanabe M; Nakahata S; Hamasaki M; Saito Y; Kawano Y; Hidaka T; Yamashita K; Umeki K; Taki T; Taniwaki M; Okayama A; Morishita K
J Virol; 2010 Jul; 84(14):6966-77. PubMed ID: 20444901
[TBL] [Abstract][Full Text] [Related]
25. Mutation Analysis for TP53 in Chronic-Type Adult T-Cell Leukemia/Lymphoma.
Yoshida N; Imaizumi Y; Utsunomiya A; Miyoshi H; Arakawa F; Tsukasaki K; Ohshima K; Seto M
J Clin Exp Hematop; 2015; 55(1):13-6. PubMed ID: 26106001
[TBL] [Abstract][Full Text] [Related]
26. Development of a complete human IgG monoclonal antibody to transferrin receptor 1 targeted for adult T-cell leukemia/lymphoma.
Shimosaki S; Nakahata S; Ichikawa T; Kitanaka A; Kameda T; Hidaka T; Kubuki Y; Kurosawa G; Zhang L; Sudo Y; Shimoda K; Morishita K
Biochem Biophys Res Commun; 2017 Mar; 485(1):144-151. PubMed ID: 28189691
[TBL] [Abstract][Full Text] [Related]
27. Targeting the HTLV-I-Regulated BATF3/IRF4 Transcriptional Network in Adult T Cell Leukemia/Lymphoma.
Nakagawa M; Shaffer AL; Ceribelli M; Zhang M; Wright G; Huang DW; Xiao W; Powell J; Petrus MN; Yang Y; Phelan JD; Kohlhammer H; Dubois SP; Yoo HM; Bachy E; Webster DE; Yang Y; Xu W; Yu X; Zhao H; Bryant BR; Shimono J; Ishio T; Maeda M; Green PL; Waldmann TA; Staudt LM
Cancer Cell; 2018 Aug; 34(2):286-297.e10. PubMed ID: 30057145
[TBL] [Abstract][Full Text] [Related]
28. Targeting HTLV-1 activation of NFκB in mouse models and ATLL patients.
Rauch DA; Ratner L
Viruses; 2011 Jun; 3(6):886-900. PubMed ID: 21994759
[TBL] [Abstract][Full Text] [Related]
29. Molecular Pathology of Adult T-Cell Leukemia/Lymphoma.
Ohshima K
Oncology; 2015; 89 Suppl 1():7-15. PubMed ID: 26550829
[TBL] [Abstract][Full Text] [Related]
30. Genome-wide CRISPR screens identify CD48 defining susceptibility to NK cytotoxicity in peripheral T-cell lymphomas.
Chiba M; Shimono J; Ishio T; Takei N; Kasahara K; Ogasawara R; Ara T; Goto H; Izumiyama K; Otsuguro S; Perera LP; Hasegawa H; Maeda M; Hashino S; Maenaka K; Teshima T; Waldmann TA; Yang Y; Nakagawa M
Blood; 2022 Nov; 140(18):1951-1963. PubMed ID: 35921533
[TBL] [Abstract][Full Text] [Related]
31. Anti-adult T-cell leukemia/lymphoma effects of indole-3-carbinol.
Machijima Y; Ishikawa C; Sawada S; Okudaira T; Uchihara JN; Tanaka Y; Taira N; Mori N
Retrovirology; 2009 Jan; 6():7. PubMed ID: 19146708
[TBL] [Abstract][Full Text] [Related]
32. Small PARP inhibitor PJ-34 induces cell cycle arrest and apoptosis of adult T-cell leukemia cells.
Bai XT; Moles R; Chaib-Mezrag H; Nicot C
J Hematol Oncol; 2015 Oct; 8():117. PubMed ID: 26497583
[TBL] [Abstract][Full Text] [Related]
33. Clinical activity of 9-ING-41, a small molecule selective glycogen synthase kinase-3 beta (GSK-3β) inhibitor, in refractory adult T-Cell leukemia/lymphoma.
Hsu A; Huntington KE; De Souza A; Zhou L; Olszewski AJ; Makwana NP; Treaba DO; Cavalcante L; Giles FJ; Safran H; El-Deiry WS; Carneiro BA
Cancer Biol Ther; 2022 Dec; 23(1):417-423. PubMed ID: 35815408
[TBL] [Abstract][Full Text] [Related]
34. Targeting the CDK6 Dependence of Ph+ Acute Lymphoblastic Leukemia.
Porazzi P; De Dominici M; Salvino J; Calabretta B
Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573335
[TBL] [Abstract][Full Text] [Related]
35. Dual inhibition of the mTORC1 and mTORC2 signaling pathways is a promising therapeutic target for adult T-cell leukemia.
Kawata T; Tada K; Kobayashi M; Sakamoto T; Takiuchi Y; Iwai F; Sakurada M; Hishizawa M; Shirakawa K; Shindo K; Sato H; Takaori-Kondo A
Cancer Sci; 2018 Jan; 109(1):103-111. PubMed ID: 29077243
[TBL] [Abstract][Full Text] [Related]
36. miR-497 suppresses cycle progression through an axis involving CDK6 in ALK-positive cells.
Hoareau-Aveilla C; Quelen C; Congras A; Caillet N; Labourdette D; Dozier C; Brousset P; Lamant L; Meggetto F
Haematologica; 2019 Feb; 104(2):347-359. PubMed ID: 30262555
[TBL] [Abstract][Full Text] [Related]
37. LBH589, a deacetylase inhibitor, induces apoptosis in adult T-cell leukemia/lymphoma cells via activation of a novel RAIDD-caspase-2 pathway.
Hasegawa H; Yamada Y; Tsukasaki K; Mori N; Tsuruda K; Sasaki D; Usui T; Osaka A; Atogami S; Ishikawa C; Machijima Y; Sawada S; Hayashi T; Miyazaki Y; Kamihira S
Leukemia; 2011 Apr; 25(4):575-87. PubMed ID: 21242994
[TBL] [Abstract][Full Text] [Related]
38. North American ATLL has a distinct mutational and transcriptional profile and responds to epigenetic therapies.
Shah UA; Chung EY; Giricz O; Pradhan K; Kataoka K; Gordon-Mitchell S; Bhagat TD; Mai Y; Wei Y; Ishida E; Choudhary GS; Joseph A; Rice R; Gitego N; Parrish C; Bartenstein M; Goel S; Mantzaris I; Shastri A; Derman O; Binder A; Gritsman K; Kornblum N; Braunschweig I; Bhagat C; Hall J; Graber A; Ratner L; Wang Y; Ogawa S; Verma A; Ye BH; Janakiram M
Blood; 2018 Oct; 132(14):1507-1518. PubMed ID: 30104217
[TBL] [Abstract][Full Text] [Related]
39. Adult T-cell leukemia/lymphoma.
Rasul KI; Barwari ZA
Gulf J Oncolog; 2012 Jul; (12):27-37. PubMed ID: 22773213
[TBL] [Abstract][Full Text] [Related]
40. Mutation analysis of mitotic checkpoint genes (hBUB1 and hBUBR1) and microsatellite instability in adult T-cell leukemia/lymphoma.
Ohshima K; Haraoka S; Yoshioka S; Hamasaki M; Fujiki T; Suzumiya J; Kawasaki C; Kanda M; Kikuchi M
Cancer Lett; 2000 Oct; 158(2):141-50. PubMed ID: 10960763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
